179 related articles for article (PubMed ID: 22205345)
1. New brain-specific beta-synuclein isoforms show expression ratio changes in Lewy body diseases.
Beyer K; Munoz-Marmol AM; Sanz C; Marginet-Flinch R; Ferrer I; Ariza A
Neurogenetics; 2012 Feb; 13(1):61-72. PubMed ID: 22205345
[TBL] [Abstract][Full Text] [Related]
2. Alpha- and beta-synuclein expression in Parkinson disease with and without dementia.
Beyer K; Ispierto L; Latorre P; Tolosa E; Ariza A
J Neurol Sci; 2011 Nov; 310(1-2):112-7. PubMed ID: 21683963
[TBL] [Abstract][Full Text] [Related]
3. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies.
Beyer K; Domingo-Sàbat M; Santos C; Tolosa E; Ferrer I; Ariza A
Brain; 2010 Dec; 133(Pt 12):3724-33. PubMed ID: 20959308
[TBL] [Abstract][Full Text] [Related]
4. INDEL Length and Haplotypes in the β-Synuclein Gene: A Key to Differentiate Dementia with Lewy Bodies?
Gámez-Valero A; Canet-Pons J; Urbizu A; Anillo A; Santos C; Ariza A; Beyer K
J Alzheimers Dis; 2018; 65(1):207-219. PubMed ID: 30040713
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases.
Beyer K; Domingo-Sábat M; Lao JI; Carrato C; Ferrer I; Ariza A
Neurogenetics; 2008 Feb; 9(1):15-23. PubMed ID: 17955272
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients.
Evans T; Kok WL; Cowan K; Hefford M; Anichtchik O
Brain Res; 2018 Feb; 1681():1-13. PubMed ID: 29278715
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease.
Beyer K; Domingo-Sàbat M; Humbert J; Carrato C; Ferrer I; Ariza A
Neurogenetics; 2008 Jul; 9(3):163-72. PubMed ID: 18335262
[TBL] [Abstract][Full Text] [Related]
8. Glucocerebrosidase regulators SCARB2 and TFEB are up-regulated in Lewy body disease brain.
Pérez-Roca L; Prada-Dacasa P; Segú-Vergés C; Gámez-Valero A; Serrano-Muñoz MA; Santos C; Beyer K
Neurosci Lett; 2019 Jul; 706():164-168. PubMed ID: 31116970
[TBL] [Abstract][Full Text] [Related]
9. Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson's Disease.
Marsal-García L; Urbizu A; Arnaldo L; Campdelacreu J; Vilas D; Ispierto L; Gascón-Bayarri J; Reñé R; Álvarez R; Beyer K
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33450872
[TBL] [Abstract][Full Text] [Related]
10. Regional Overlap of Pathologies in Lewy Body Disorders.
Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
[TBL] [Abstract][Full Text] [Related]
11. Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.
Fujita M; Ho G; Takamatsu Y; Wada R; Ikeda K; Hashimoto M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325870
[TBL] [Abstract][Full Text] [Related]
12. Low alpha-synuclein 126 mRNA levels in dementia with Lewy bodies and Alzheimer disease.
Beyer K; Humbert J; Ferrer A; Lao JI; Carrato C; López D; Ferrer I; Ariza A
Neuroreport; 2006 Aug; 17(12):1327-30. PubMed ID: 16951579
[TBL] [Abstract][Full Text] [Related]
13. Beta-synuclein gene alterations in dementia with Lewy bodies.
Ohtake H; Limprasert P; Fan Y; Onodera O; Kakita A; Takahashi H; Bonner LT; Tsuang DW; Murray IV; Lee VM; Trojanowski JQ; Ishikawa A; Idezuka J; Murata M; Toda T; Bird TD; Leverenz JB; Tsuji S; La Spada AR
Neurology; 2004 Sep; 63(5):805-11. PubMed ID: 15365127
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies.
Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):601-7. PubMed ID: 15541000
[TBL] [Abstract][Full Text] [Related]
15. Lewy- and Alzheimer-type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum.
Sierra M; Gelpi E; Martí MJ; Compta Y
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):451-62. PubMed ID: 26810462
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H β-synuclein.
Sekigawa A; Fujita M; Sekiyama K; Takamatsu Y; Hatano T; Rockenstein E; La Spada AR; Masliah E; Hashimoto M
Mol Brain; 2012 Sep; 5():34. PubMed ID: 23013868
[TBL] [Abstract][Full Text] [Related]
17. Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.
Walker DG; Lue LF; Adler CH; Shill HA; Caviness JN; Sabbagh MN; Akiyama H; Serrano GE; Sue LI; Beach TG;
Exp Neurol; 2013 Feb; 240():190-204. PubMed ID: 23201181
[TBL] [Abstract][Full Text] [Related]
18. Confluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.
Colom-Cadena M; Gelpi E; Charif S; Belbin O; Blesa R; Martí MJ; Clarimón J; Lleó A
J Neuropathol Exp Neurol; 2013 Dec; 72(12):1203-12. PubMed ID: 24226269
[TBL] [Abstract][Full Text] [Related]
19. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
20. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
Jellinger KA
Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
